February 02, 2026

Why So Many on BP Meds Still Miss Target

Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.

Conexiant

January 30, 2026

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.

Conexiant

January 29, 2026

Quadruple Therapy in HFrEF: What Happens Next?

Study finds high mortality and rehospitalization rates despite guideline-recommended treatment among Medicare beneficiaries.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 20, 2026

Can Social Factors Derail Bariatric Gains?

ARMMS-T2D analysis finds bariatric surgery outperforms medical therapy for type 2 diabetes regardless of neighborhood deprivation.

Conexiant

January 15, 2026

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Conexiant

January 14, 2026

US Heart Health Progress Stalls

New US cardiovascular statistics document persistent gaps in prevention and treatment across hypertension, diabetes, obesity, and cholesterol management, with marked disparities by age, income, and race.

Conexiant

January 13, 2026

FDA Drops Warning From GLP-1 RAs

The FDA asked manufacturers to remove suicidal ideation and behavior warnings from select GLP-1 RAs after a comprehensive safety evaluation.

Conexiant

January 13, 2026

FDA Drops Warning From GLP-1 RAs

The FDA asked manufacturers to remove suicidal ideation and behavior warnings from select GLP-1 RAs after a comprehensive safety evaluation.

Conexiant